Research Journal of Pharmaceutical Dosage Form and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

The Insidious Disease from Insects: Lyme Disease


Affiliations
1 Department of Pharmaceutics, Vishnu Institute of Pharmaceutical Education and Research, Vishnupur, Narsapur, Medak, Telangana, India
2 Department of Pharmacology, Vishnu Institute of Pharmaceutical Education and Research, Vishnupur, Narsapur, Medak District– 502313, Telangana, India
     

   Subscribe/Renew Journal


Lyme disease is medically described as occurring in three phases, each with distinctive symptoms. The first phase is early localized disease, which occurs three to 30 days after the tick bite that transmitted the infection. This stage is characterized by skin inflammation. The rash that occurs is referred to as erythema migrans. It develops in about 70% of people who get Lyme disease. It starts at the site of the tick bite and expands over the next several days. It can eventually cover an area up to about 12 inches across. Some of the area may clear, giving the rash at times a bull's-eye appearance.

Keywords

The Insidious Disease from Insects, Lyme Disease, Disease from Insects.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Allen C, Steere, Jenifer Coburn, Lisa Glickstein, "The emergence of Lyme disease" J Clin Invest. 2004 Apr 15; 113(8): Pages 1093-1101.

  • Mead PS, "Epidemiology of Lyme disease" Infect Dis Clin North Am. 2015 Jun; 29(2): Pages 187-210.

  • Priem S, Burmester GR, Kamradt T, Wolbart K, Rittig MG, Krause A. Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Ann Rheum Dis. 1998; 57:118–121.

  • S.K.Singh, H.J.Girschick, "Lyme borreliosis: from infection to autoimmunity", Clinical Microbiology and Infection, Volume 10, Issue 7, July 2004, Pages 598-614.

  • Hermann J Girschick, Henner Morbach, Dennis Tappe "Treatment of Lyme borreliosis" Arthritis Res Ther. 2009; 11(6): 258.

  • Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T. Lyme borreliosis. Lancet Infect Dis. 2003; 3:489–500.

  • Maraspin V, Ruzic-Sabljic E, Strle F. Lyme borreliosis and Borrelia spielmanii. Emerg Infect Dis. 2006; 12:1177.

  • Herzberger P, Siegel C, Skerka C, Fingerle V, Schulte-Spechtel U, van Dam A, Wilske B, Brade V, Zipfel PF, Wallich R, Kraiczy P. Human pathogenic Borrelia spielmanii sp. nov. resists complement-mediated killing by direct binding of immune regulators factor H and factor H-like protein 1. Infect Immun. 2007; 75:4817–4825.

  • Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med. 1996; 335:1270–1274.

  • Huppertz HI, Bohme M, Standaert SM, Karch H, Plotkin SA. Incidence of Lyme borreliosis in the Wurzburg region of Germany. Eur J Clin Microbiol Infect Dis. 1999; 18:697–703.


Abstract Views: 198

PDF Views: 1




  • The Insidious Disease from Insects: Lyme Disease

Abstract Views: 198  |  PDF Views: 1

Authors

Chiluveri Sanjuna
Department of Pharmaceutics, Vishnu Institute of Pharmaceutical Education and Research, Vishnupur, Narsapur, Medak, Telangana, India
Pindrathi Pravalika
Department of Pharmaceutics, Vishnu Institute of Pharmaceutical Education and Research, Vishnupur, Narsapur, Medak, Telangana, India
Chikoti Sneha Priya
Department of Pharmaceutics, Vishnu Institute of Pharmaceutical Education and Research, Vishnupur, Narsapur, Medak, Telangana, India
M. Venkataswamy
Department of Pharmaceutics, Vishnu Institute of Pharmaceutical Education and Research, Vishnupur, Narsapur, Medak, Telangana, India
Alluri Ramesh
Department of Pharmacology, Vishnu Institute of Pharmaceutical Education and Research, Vishnupur, Narsapur, Medak District– 502313, Telangana, India

Abstract


Lyme disease is medically described as occurring in three phases, each with distinctive symptoms. The first phase is early localized disease, which occurs three to 30 days after the tick bite that transmitted the infection. This stage is characterized by skin inflammation. The rash that occurs is referred to as erythema migrans. It develops in about 70% of people who get Lyme disease. It starts at the site of the tick bite and expands over the next several days. It can eventually cover an area up to about 12 inches across. Some of the area may clear, giving the rash at times a bull's-eye appearance.

Keywords


The Insidious Disease from Insects, Lyme Disease, Disease from Insects.

References